Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

carsl consulting - buprenorphine 160mg - injection (depot) - active: buprenorphine 160mg excipient: glyceryl dioleate soybean phosphatidylcholine n-methylpyrrolidone - buvidal monthly is indicated for maintenance treatment of opioid dependence within a framework of medical, social and psychological support.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

carsl consulting - diphenhydramine hydrochloride 50mg - tablet - 50 mg - active: diphenhydramine hydrochloride 50mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - prevention and treatment of motion sickness.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

carsl consulting - diphenhydramine hydrochloride 50mg - tablet - 50 mg - active: diphenhydramine hydrochloride 50mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - prevention and treatment of motion sickness.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

carsl consulting - thiotepa 100mg - powder for infusion - 100 mg - active: thiotepa 100mg - indicated, in combination with other chemotherapy medicinal products: - with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients; - when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

carsl consulting - thiotepa 15mg - powder for infusion - 15 mg - active: thiotepa 15mg - indicated, in combination with other chemotherapy medicinal products: - with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients; - when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

meda pharmaceuticals pty ltd - pimecrolimus -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - movapo is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with movapo should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 20 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - movapo is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with movapo should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - ciclosporin, quantity: 900 microgram/ml - eye drops - excipient ingredients: peg-40 hydrogenated castor oil; octoxinol 40; monobasic sodium phosphate dihydrate; dibasic sodium phosphate; sodium chloride; povidone; water for injections; hydrochloric acid; sodium hydroxide - cequa is indicated to increase tear production in patients with moderate to severe keratoconjunctivitis sicca (dry eye) where prior use of artificial tears has not been sufficient.